Aquis Exchange PLC Reports 2024 Results Amidst SIX Group Acquisition Progress
Aquis Exchange PLC's 2024 results: £23.8m revenue as SIX Group acquisition progresses. Markets & Data divisions drive growth despite economic challenges.
This article covers information on Aquis Exchange PLC.
LON:AQXThe Big Picture: Steady Revenue Amidst Transformative Moves
Let’s cut through the noise: Aquis Exchange PLC’s 2024 results are a tale of resilience, strategic chess moves, and a pending acquisition that could reshape its future. While gross revenue nudged up 0.3% to £23.8m, the headline loss before tax of £2.2m tells a more nuanced story. Here’s what investors need to know.
Financial Snapshot: The Good, The Bad, and The Exceptional
On the surface, the numbers might seem contradictory:
- Gross revenue: £23.8m (up from £23.7m in 2023)
- Net revenue: £20.1m (down 11% YoY)
- Adjusted PBT: £1.1m (vs £5.2m in 2023)
- Cash reserves: £13.7m (down from £14.8m)
The £3.3m exceptional costs tied to the SIX Group acquisition explain much of the squeeze. Strip those out, and the underlying business shows grit in choppy markets – though credit provisions against two tech clients (£3.7m) and a non-renewed contract added pressure.
Division Deep Dive: Where the Action Is
Markets Division: The Steady Performer
Aquis Markets delivered 7.8% revenue growth to £11.8m, driven by:
- Conditional orders adoption (10 users, €72m daily peak)
- Market share uptick to 5.22% (from 5.11%)
- Expanded tradable universe to 6,500+ instruments
Data Division: The Silent Growth Engine
Revenue surged 33% to £5m – a full year of member data fees plus five new clients. With EU/UK consolidated tape regulations looming from 2026, this could become Aquis’ secret weapon.
Technologies Division: The Recovery Play
A 74.9% net revenue drop to £1.6m stings, but look deeper:
- Record contract pipeline growth
- New RFP progress with a national exchange group
- Two existing clients accounting for majority of credit provisions
This remains the division with the highest upside potential – if management can convert its pipeline.
The SIX Factor: Acquisition Dynamics
The £N/A Recommended Cash Offer (terms undisclosed) is progressing:
- Shareholder approval secured in Dec 2024
- Antitrust hurdles cleared
- Regulatory approvals expected Q2 2025
CEO David Stevens positions this as “an exciting next step to accelerate development” – corporate speak, but arguably true given SIX’s continental heft.
Leadership Shuffle: Continuity Over Revolution
The board changes matter:
- New Chair Deirdre Somers (ex-LSE exec) taking reins
- Founder Alasdair Haynes stepping back as CEO (health reasons)
- David Stevens promoted from COO – a safe pair of hands
Not a clean sweep, but enough fresh blood to navigate the SIX integration.
Forward Look: Catalysts and Caveats
2025 will be decisive:
- Q2: Expected SIX deal completion
- H2: Potential tech division contract wins
- Wildcard: Primary market recovery for AQSE
The £13.7m cash warchest provides breathing room, though £3m+ spent on acquisition costs already shows the price of transformation.
Final Take: Aquis at an Inflection Point
This isn’t just another financial results story – it’s a pivot point. The SIX acquisition could either supercharge Aquis’ pan-European ambitions or see it absorbed into a larger machine. For investors, the next six months are critical. Watch for:
- Regulatory approval timelines
- Tech division pipeline conversions
- AQSE’s ability to capitalise on any IPO market thaw
One thing’s clear – in an era of exchange consolidation, Aquis remains determined to punch above its weight. Whether that’s as an independent entity or part of SIX, 2025 will write the next chapter.
Related
Keep reading
Investing
AstraZeneca’s Enhertu delivers Phase III lung cancer PFS win
Enhertu delayed disease progression versus standard care in a Phase III lung cancer trial, supporting its potential move into first-line treatment.
JoshuaAugust 17, 2026
Investing
Optima Health FY26 results: growth beats expectations as PAM integration begins
Optima Health beat adjusted EBITDA expectations in FY26, while the £100 million PAM acquisition reshaped its growth prospects and balance sheet.
JoshuaAugust 17, 2026
Investing
Nostrum Oil & Gas Agrees $304.6 Million Kazakhstan Sale Ahead of Wind-Down
Nostrum plans to sell its Kazakhstan operations, repay secured notes in full and begin an orderly wind-down after completion.
JoshuaAugust 17, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.